Skip to the page

Data / Form D filings / Stride Therapy, Inc.

Stride Therapy, Inc.: Form D filings

Stride Therapy, Inc., a technology company in Brooklyn, NY, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on June 12, 2024, reports $3.5 million sold of a $5 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
41 FLATBUSH AVE, STE 225, Brooklyn, NY, 11217
Phone
(484) 838-6258
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1920819

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 12, 2024New notice$5,000,000$3,500,000$1,500,00018May 28, 2024sec.gov
Apr 1, 2022New notice$2,500,000$2,500,0003Mar 25, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan LimorExecutive Officer, Director, Promoter
Daniel BlankExecutive Officer, Director, Promoter

Other technology companies in New York that filed recently

Every Form D from the week of Jun 10, 2024 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Stride Therapy, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.